{"database": "openregs", "table": "documents", "rows": [["FDA-2012-D-0529-0006", "FDA", "FDA-2012-D-0529", "Recommended Statement for Over-the-Counter Aspirin-Containing Drug\nProducts Labeled With Cardiovascular Related Imagery; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2017-01-11T05:00:00Z", 2017, 1, "2017-01-11T05:00:00Z", "2017-03-14T03:59:59Z", "2017-03-14T01:02:02Z", "2017-00374", 0, 0, "090000648245aff6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2012-D-0529-0006"], "units": {}, "query_ms": 1.315792091190815, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}